EPS Bio Technology Corp. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was TWD 116.28 million compared to TWD 146.37 million a year ago. Revenue was TWD 116.28 million compared to TWD 146.37 million a year ago. Net income was TWD 10.31 million compared to TWD 15.25 million a year ago. Basic earnings per share from continuing operations was TWD 0.43 compared to TWD 0.64 a year ago. Diluted earnings per share from continuing operations was TWD 0.43 compared to TWD 0.64 a year ago.
For the nine months, sales was TWD 319.54 million compared to TWD 359.43 million a year ago. Revenue was TWD 319.54 million compared to TWD 359.43 million a year ago. Net income was TWD 16.91 million compared to TWD 22.7 million a year ago. Basic earnings per share from continuing operations was TWD 0.71 compared to TWD 0.95 a year ago. Diluted earnings per share from continuing operations was TWD 0.71 compared to TWD 0.95 a year ago.